How the Drone Industry Can Expand its Regulatory Boundaries

 

As a burgeoning industry, drone companies are setting new boundaries every day. Their diverse set of uses makes them applicable to many other diverse business sectors, including energy, agriculture and engineering. With that, comes excitement but also uncertainty, and regulation remains a hurdle for both manufacturers of drones and their ultimate end users.

Leaders in the drone space will have to strategically operate under the current guidelines, but there is debate amongst industry insiders about how to improve their regulatory prospects going forward.

At Commercial UAV Expo Americas, these leaders gathered to address issues exactly like this. One speaker was Mike Blades, VP, Aerospace, Defense, and Security Americas Region at consulting firm Frost & Sullivan.

He explained to MarketScale that drone companies would be wise to utilize business partners in their battle for regulatory reform. Explaining how specific industries can see a quick return on investment (ROI) is a good start.

“Telling that (ROI) story I think is more important that telling the regulatory story because if you can get those business leaders, those C-level executives, to sign on to and understand it, you can present them with information that says yes, we need to bring drones in, or no, that’s not enough ROI,” Blades said.

He further stated that by getting other industry leaders to pitch change on their behalf would go a long way.

“The regulatory will follow because there will be more pressure from those industries to say ‘look, we need more support on the regulatory side because we’re adopting at a greater rate’,” Blades said.

Regulation may be hampering some of what drones can do today, but by succeeding at what they provide under the current set of rules, they will put themselves in a better position to grow in the future.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More